| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_41ca9b060cc324d126a65f7b6f529acc |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K33-12
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2009
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2018
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2054
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-2059
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-08 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-454
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-08 |
| filingDate |
2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_3f50c756eb97cd96b2859251e7ca1ed7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5171d57f7f9554cea7e87a806b59fb2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1eaa8899ba7ea1f78fffbd3da47be195
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e392614da08f0efee872bf20d302961
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9a05a357a11b4b41828a1a9241d05666
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e0facb30006ec4c6de140d83dabe9306
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f6fa1b914136d04fca2ec5296a3d68ee |
| publicationDate |
2019-05-23-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2019097090-A1 |
| titleOfInvention |
Pharmaceutical tablet composition comprising bilastine and magnesium aluminometasilicate |
| abstract |
The invention relates to a pharmaceutical composition in the form of a tablet, comprising bilastine and magnesium aluminometasilicate. The invention further relates to a method of preparing a pharmaceutical composition in the form of a tablet comprising dry granulation of a blend of the tablet components and compression of the granules to a tablet, or direct compression of a blend to a tablet. The invention relates further to the medical use of the pharmaceutical composition in the treatment of allergic rhino-conjunctivitis and/or urticaria. |
| priorityDate |
2017-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |